BSE filing, BSE: 543594. Summary written from the filing by ALFA Finder's alert engine.
Dipna Pharmachem Ltd: key numbers
- Share price
- ₹4.00
- Market cap
- ₹10.52 Cr
- Revenue (annual)
- ₹129.1 Cr
- Net profit (annual)
- ₹2.63 Cr
- P/E (TTM)
- 4.0×Sector 47.2×
- Promoter holding
- 9.13%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dipna Pharmachem Ltd
All →Dipna Pharmachem Board Meeting Date
Dipna Pharmachem's board meets on 4 November 2026 to consider unaudited results for the quarter ended 30 June 2026. The meeting has not yet been held.
Dipna Pharmachem Management Change
Dipna Pharmachem appointed Shyam Sundar Lohia as Company Secretary and Compliance Officer effective August 5, 2026. The board approved the appointment at its August 5 meeting.
Dipna Pharmachem Other Announcement
Dipna Pharmachem Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI regulations.
Dipna Pharmachem Other Announcement
Dipna Pharmachem Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR, detailing the distribution of equity shares.
Dipna Pharmachem Q4 FY26 Results: Net Profit ₹0.2 Cr, Down 60.0% YoY
Dipna Pharmachem Ltd reported revenue from operations of ₹2.1 Cr (-86.8% YoY) and net profit of ₹0.2 Cr (-60.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹0.2 Cr · -60.0% YoY
Dipna Pharmachem Management Change
Dipna Pharmachem appointed two new Independent Directors effective May 11, 2026. Board committees were also reconstituted to enhance governance.
Other management change announcements
All →Shalimar Paints Management Change
Shalimar Paints' non-executive director Abhijeet Jhawar resigned effective November 3, 2026, citing personal reasons. The board-level change carries no disclosed financial value.
Sword-Edge Commercials Management Change
Sword-Edge Commercials appointed Tushar Parekh as Executive Director for 36 months from 3 November 2026. It also appointed Disha Ramani & Associates as Secretarial Auditor.
Praveg Management Change
Praveg Limited's Company Secretary and Compliance Officer, Mukeshkumar Chaudhary, resigned effective November 3, 2026. Himalay Dudharejiya was appointed in his place from the same date.
DAM Capital Advisors Management Change
DAM Capital Advisors appointed Kishor Purshottam Thakkar as Non-Executive Independent Director for 60 months. Rajendra Prabhakar Chitale's tenure as Non-Executive Independent Director completed, with both changes effective 14 December 2026.
Vijaya Diagnostic Centre Management Change
Vijaya Diagnostic Centre appointed Rahul Jain as Company Secretary and Compliance Officer, designated KMP, effective November 03, 2026. The appointment follows the Nomination and Remuneration Committee's recommendation.
Endurance Technologies Management Change
Endurance Technologies' Compliance Officer Sunil Lalai resigned, effective 16 Nov 2026. Mandar Velankar is appointed Compliance Officer from the same date.